UBS Group’s Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value AIZP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-113
Closed -$13K 9048
2020
Q3
$13K Sell
113
-1,267
-92% -$145K ﹤0.01% 6679
2020
Q2
$144K Sell
1,380
-616
-31% -$64.8K ﹤0.01% 5042
2020
Q1
$213K Buy
1,996
+144
+8% +$17.5K ﹤0.01% 4674
2019
Q4
$238K Buy
1,852
+22
+1% +$2.8K ﹤0.01% 5481
2019
Q3
$229K Buy
1,830
+1,040
+132% +$125K ﹤0.01% 5147
2019
Q2
$88K Sell
790
-154
-16% -$16.4K ﹤0.01% 5468
2019
Q1
$98K Buy
944
+10
+1% +$1.05K ﹤0.01% 5089
2018
Q4
$92K Sell
934
-150
-14% -$15.9K ﹤0.01% 5609
2018
Q3
$123K Sell
1,084
-182
-14% -$20.6K ﹤0.01% 5414
2018
Q2
$142K Buy
+1,266
New +$134K ﹤0.01% 5194

Other funds holding AIZP

UBS Group's AIZP Position: Q4 2020 in Review

UBS Group sold out of Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value (AIZP) in Q4 2020, closing a stake of 113 shares — an estimated $13K sold.

UBS Group first reported a position in AIZP in Q2 2018 and held it in 10 quarters. The position peaked at $238K in Q4 2019. 5 funds tracked by Wall St. Rank hold AIZP as of Q4 2020.

  • UBS Group reported no remaining Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value position as of Q4 2020 after selling out during the quarter.
  • UBS Group sold 113 Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value shares in Q4 2020, an estimated $13K.
  • UBS Group first reported a position in Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value in Q2 2018 and held it in 10 quarters.
  • UBS Group's Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value position peaked at $238K in Q4 2019.
  • 5 funds tracked by Wall St. Rank held Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.